AI-generated summary
The authors describe a single patient with locally advanced nasopharyngeal carcinoma who received preemptive photobiomodulation with a 904 nm laser and a self-applied 600 nm laser during chemoradiation. The patient developed only mild to moderate oral mucositis, and the authors report this as a possible benefit of the approach. As a single case study without a control group, the findings cannot establish effectiveness.
- Participants
- 1
- Who or what was studied
- One patient with locally advanced (stage II) nasopharyngeal squamous cell carcinoma receiving primary chemoradiation
- Wavelengths
- 904, 600 nm
- Limits stated in the abstract
- The report is a single high-risk case study with no control group, and the authors state that further studies are required.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on karger.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 904 nm, 600 nm
- Power
- 200 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Laser, Near-infrared, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.